— Know what they know.
Not Investment Advice

CCRN NASDAQ

Cross Country Healthcare, Inc.
1W: +0.0% 1M: +0.5% 3M: +31.7% YTD: +64.4% 1Y: -2.5% 3Y: -52.3% 5Y: -13.8%
$13.25
Last traded 2026-07-28 — delisted
NASDAQ · Industrials · Staffing & Employment Services · $428.1M mcap · 30M float · 2.54% daily turnover · Short 30% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.3 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: -7.9%  ·  5Y Avg: 15.4%
Cost Advantage
49
Intangibles
26
Switching Cost
28
Network Effect
23
Scale ★
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CCRN has No discernible competitive edge (34.3/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. Negative ROIC of -7.9% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$11
Avg Target
$11
High
Based on 6 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 12Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$10.61
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-05 Cross Research Bill Sutherland Initiated $14 — +44.6% $9.68
2026-02-03 Wedbush — Initiated $11 — +18.4% $9.29
2025-12-16 Truist Financial — Initiated $10 — +22.5% $8.16
2025-12-09 UBS — Initiated $9 — +10.6% $8.14
2025-12-04 Jefferies Jack Slevin Initiated $9 — +16.0% $7.46
2025-12-04 JMP Securities Constantine Davides Initiated $11 — +47.5% $7.46
2024-05-06 Barrington Kevin Steinke Initiated $21 — +26.7% $16.58

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 32 Grade D
Profitability
5
Balance Sheet
17
Earnings Quality
24
Growth
16
Value
41
Momentum
23
Safety
90
Cash Flow
43
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CCRN scores highest in Safety (90/100) and lowest in Profitability (5/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.81
Safe Zone
Piotroski F-Score
5/9
✗ ✓ ✗ ✓ ✓ ✓ ✓ ✗ ✗
Beneish M-Score
-4.36
Unlikely Manipulator
Ohlson O-Score
-7.68
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 61.3/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -0.48x
Accruals: -28.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CCRN scores 3.81, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CCRN scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CCRN's score of -4.36 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CCRN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CCRN receives an estimated rating of BBB+ (score: 61.3/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-4.34x
PEG
0.03x
P/S
0.43x
P/B
1.33x
P/FCF
7.47x
P/OCF
6.25x
EV/EBITDA
-2.81x
EV/Revenue
0.19x
EV/EBIT
-2.29x
EV/FCF
4.85x
Earnings Yield
-33.34%
FCF Yield
13.39%
Shareholder Yield
4.19%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CCRN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.142
NI / EBT
×
Interest Burden
1.027
EBT / EBIT
×
EBIT Margin
-0.084
EBIT / Rev
×
Asset Turnover
1.951
Rev / Assets
×
Equity Multiplier
1.405
Assets / Equity
=
ROE
-27.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CCRN's ROE of -27.0% is driven by Asset Turnover (1.951), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.14 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$13.25
Median 1Y
$12.10
5th Pctile
$4.62
95th Pctile
$31.73
Ann. Volatility
58.9%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 20.1% 32.3% 58.4% 66.0% 71.7% 71.1% 49.9% 38.6% 28.2% 22.9% 15.6% 10.0% 1.9% -0.4% -3.3% -4.0% -2.0% -3.8% -25.6% -27.0% -26.98%
ROA 8.1% 13.4% 24.2% 25.7% 30.1% 32.4% 22.4% 17.0% 14.5% 12.9% 8.9% 5.8% 1.2% -0.3% -2.3% -2.9% -1.4% -2.8% -18.3% -19.2% -19.20%
ROIC 12.3% 18.9% 28.1% 30.8% 36.1% 44.9% 32.8% 28.2% 27.1% 24.6% 17.2% 10.6% 2.4% 0.0% -3.9% -4.8% -1.8% -4.1% -7.3% -7.9% -7.88%
ROCE 14.1% 20.1% 27.2% 34.0% 40.8% 50.4% 41.5% 35.5% 34.6% 29.3% 21.9% 15.2% 6.0% 2.8% -0.1% -1.9% -0.3% -2.3% -21.9% -23.3% -23.33%
Gross Margin 21.9% 22.4% 23.0% 22.2% 22.6% 22.6% 22.1% 22.4% 22.8% 22.0% 21.9% 20.4% 20.8% 20.4% 20.0% 20.0% 20.4% 20.4% 20.3% 18.2% 18.22%
Operating Margin 4.8% 7.1% 11.9% 11.5% 10.5% 8.2% 8.2% 7.0% 6.5% 4.6% 3.2% 0.8% -5.7% 0.9% -1.1% -0.3% -2.1% -2.4% -3.0% -0.8% -0.81%
Net Margin 3.5% 6.3% 12.1% 7.9% 7.0% 5.5% 6.2% 4.7% 3.9% 2.9% 2.2% 0.7% -4.7% 0.8% -1.2% -0.2% -2.4% -1.9% -35.0% -1.8% -1.77%
EBITDA Margin 6.6% 7.9% 12.3% 12.1% 10.8% 9.7% 8.6% 8.1% 7.6% 5.6% 4.4% 3.4% -2.4% 2.7% 1.3% 1.5% -0.4% -0.4% -28.2% 0.2% 0.21%
FCF Margin -2.0% -1.3% -5.5% -4.6% -3.7% 1.7% 4.5% 7.6% 12.3% 10.2% 11.6% 11.0% 10.1% 6.8% 8.3% 8.9% 2.9% 4.1% 3.8% 4.0% 3.95%
OCF Margin -1.5% -0.8% -5.1% -4.2% -3.4% 2.0% 4.8% 8.0% 12.8% 10.8% 12.3% 11.7% 10.8% 7.5% 8.9% 9.5% 3.5% 4.8% 4.6% 4.7% 4.72%
ROE 3Y Avg snapshot only -8.66%
ROE 5Y Avg snapshot only 11.51%
ROA 3Y Avg snapshot only -5.96%
ROIC 3Y Avg snapshot only -1.59%
ROIC Economic snapshot only -5.60%
Cash ROA snapshot only 10.49%
Cash ROIC snapshot only 22.62%
CROIC snapshot only 18.93%
NOPAT Margin snapshot only -1.65%
Pretax Margin snapshot only -8.62%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 14.68%
SBC / Revenue snapshot only 0.70%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 17.92 13.52 7.94 4.71 3.64 4.68 5.21 5.23 8.02 8.51 10.81 14.11 55.35 -251.73 -40.34 -27.10 -50.80 -29.46 -2.76 -3.00 -4.344
P/S Ratio 0.57 0.64 0.62 0.39 0.31 0.38 0.35 0.31 0.41 0.39 0.39 0.36 0.30 0.31 0.44 0.38 0.36 0.41 0.25 0.30 0.427
P/B Ratio 3.21 3.68 3.52 2.31 1.91 2.52 2.15 1.81 2.12 1.86 1.66 1.38 1.07 1.05 1.40 1.15 1.03 1.13 0.81 0.95 1.333
P/FCF -29.14 -49.37 -11.29 -8.41 -8.27 22.48 7.83 4.09 3.34 3.83 3.35 3.32 2.95 4.49 5.27 4.32 12.44 10.11 6.53 7.47 7.469
P/OCF — — — — — 18.87 7.32 3.89 3.21 3.62 3.16 3.12 2.75 4.12 4.89 4.01 10.19 8.51 5.43 6.25 6.249
EV/EBITDA 11.85 10.80 8.02 4.69 3.51 3.69 3.88 3.89 4.99 5.07 5.76 6.68 8.54 12.34 30.21 47.30 21.93 57.68 -2.41 -2.81 -2.810
EV/Revenue 0.68 0.73 0.74 0.50 0.39 0.42 0.40 0.36 0.43 0.39 0.38 0.36 0.26 0.27 0.38 0.32 0.29 0.32 0.15 0.19 0.192
EV/EBIT 13.86 12.14 8.56 4.92 3.66 3.84 4.05 4.13 5.39 5.62 6.64 8.16 13.70 28.82 -803.62 -44.30 -275.16 -35.51 -1.91 -2.29 -2.286
EV/FCF -34.55 -56.66 -13.39 -10.83 -10.54 24.79 9.06 4.82 3.47 3.79 3.30 3.32 2.54 3.89 4.57 3.62 10.14 7.99 3.88 4.85 4.855
Earnings Yield 5.6% 7.4% 12.6% 21.2% 27.4% 21.4% 19.2% 19.1% 12.5% 11.7% 9.2% 7.1% 1.8% -0.4% -2.5% -3.7% -2.0% -3.4% -36.2% -33.3% -33.34%
FCF Yield -3.4% -2.0% -8.9% -11.9% -12.1% 4.4% 12.8% 24.5% 29.9% 26.1% 29.9% 30.1% 33.9% 22.3% 19.0% 23.2% 8.0% 9.9% 15.3% 13.4% 13.39%
PEG Ratio snapshot only 0.026
Price/Tangible Book snapshot only 1.422
EV/OCF snapshot only 4.062
EV/Gross Profit snapshot only 0.967
Shareholder Yield snapshot only 4.19%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.34 2.17 2.54 2.44 2.67 2.38 2.49 2.45 2.34 2.43 2.79 3.02 3.07 2.79 2.78 2.98 3.21 3.45 3.78 3.29 3.294
Quick Ratio 2.34 2.17 2.54 2.42 2.67 2.38 2.45 2.45 2.34 2.43 2.79 3.02 3.07 2.79 2.78 2.98 3.21 3.45 3.78 3.29 3.294
Debt/Equity 0.69 0.55 0.66 0.67 0.53 0.33 0.35 0.32 0.08 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.007
Net Debt/Equity 0.59 0.54 0.65 0.66 0.53 0.26 0.34 0.32 0.08 -0.02 -0.02 -0.00 -0.15 -0.14 -0.19 -0.19 -0.19 -0.24 -0.33 -0.33 -0.331
Debt/Assets 0.27 0.23 0.27 0.26 0.23 0.16 0.17 0.16 0.05 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.005
Debt/EBITDA 2.15 1.40 1.26 1.05 0.76 0.44 0.54 0.59 0.18 0.03 0.04 0.05 0.10 0.14 0.23 0.39 0.18 0.35 -0.04 -0.03 -0.030
Net Debt/EBITDA 1.85 1.39 1.26 1.05 0.76 0.34 0.53 0.59 0.18 -0.05 -0.09 -0.01 -1.37 -1.91 -4.61 -9.08 -4.98 -15.32 1.65 1.51 1.513
Interest Coverage 16.70 15.99 21.13 22.18 22.11 22.30 19.50 16.01 13.86 13.94 14.39 16.28 12.94 6.16 -0.29 -4.01 -0.56 -4.55 -36.69 -37.55 -37.547
Equity Multiplier 2.58 2.40 2.46 2.57 2.29 2.09 2.07 2.04 1.64 1.51 1.43 1.38 1.37 1.41 1.41 1.38 1.34 1.32 1.39 1.44 1.442
Cash Ratio snapshot only 1.166
Debt Service Coverage snapshot only -30.542
Cash to Debt snapshot only 51.681
FCF to Debt snapshot only 19.385
Defensive Interval snapshot only 481.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 2.53 2.85 3.08 3.14 3.57 4.02 3.34 2.87 2.84 2.81 2.48 2.26 2.29 2.22 2.12 2.05 2.06 1.99 2.03 1.95 1.951
Inventory Turnover — — — 431.22 — — 393.77 532.78 — — 283.60 — — — — — — — — — —
Receivables Turnover 5.19 5.33 5.05 4.63 5.34 6.18 4.94 4.05 4.09 4.37 3.98 3.61 4.33 4.42 4.51 4.36 5.37 5.30 5.40 5.05 5.055
Payables Turnover 14.29 15.94 16.31 14.80 15.79 16.47 35.54 12.01 11.43 11.31 197.36 11.29 12.70 13.22 243.57 29.09 18.18 17.86 32.47 33.75 33.747
DSO 70 69 72 79 68 59 74 90 89 83 92 101 84 83 81 84 68 69 68 72 72.2 days
DIO 0 0 0 1 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0.0 days
DPO 26 23 22 25 23 22 10 30 32 32 2 32 29 28 1 13 20 20 11 11 10.8 days
Cash Conversion Cycle 45 46 50 55 45 37 64 60 57 51 91 69 56 55 79 71 48 48 56 61 61.4 days
Fixed Asset Turnover snapshot only 34.439
Cash Velocity snapshot only 9.490
Capital Intensity snapshot only 0.450
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 25.8% 49.7% 1.0% 1.2% 1.4% 1.3% 67.4% 23.6% -5.1% -20.8% -28.0% -32.7% -35.1% -35.2% -33.5% -29.2% -24.3% -22.1% -21.6% -20.4% -20.37%
Net Income 2.7% 4.2% 11.2% 19.4% 5.3% 2.8% 42.8% -10.7% -42.4% -54.9% -61.5% -70.6% -93.2% -1.0% -1.2% -1.4% -2.0% -7.9% -5.5% -4.6% -4.56%
EPS 2.6% 4.0% 10.9% 18.9% 5.2% 2.9% 45.9% -7.2% -38.8% -51.9% -59.0% -68.9% -92.9% -1.0% -1.2% -1.4% -2.0% -8.0% -5.5% -4.7% -4.70%
FCF -3.1% -2.1% -5.1% -4.0% -3.5% 3.9% 2.4% 3.0% 4.1% 3.8% 87.2% -2.2% -46.6% -56.6% -52.5% -42.9% -78.6% -53.8% -64.0% -64.4% -64.45%
EBITDA 2.1% 2.4% 4.9% 3.8% 3.6% 2.7% 88.8% 9.5% -27.4% -46.4% -54.1% -60.8% -77.1% -81.7% -87.4% -91.2% -66.8% -79.7% -4.8% -9.0% -9.02%
Op. Income 4.6% 6.6% 17.4% 15.6% 5.4% 3.3% 96.1% 8.3% -32.8% -49.3% -58.7% -68.3% -90.4% -1.0% -1.1% -1.3% -1.4% -2029.2% -18.1% -0.6% -0.58%
OCF Growth snapshot only -60.48%
Asset Growth snapshot only -21.72%
Equity Growth snapshot only -25.20%
Debt Growth snapshot only -38.28%
Shares Change snapshot only -2.52%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 7.5% 14.4% 27.1% 38.7% 47.3% 51.7% 50.6% 46.7% 41.8% 38.8% 34.2% 23.0% 13.7% 5.0% -7.1% -16.2% -22.5% -26.3% -27.8% -27.6% -27.60%
Revenue 5Y 6.4% 9.3% 15.0% 20.4% 24.5% 26.6% 26.5% 24.9% 23.0% 21.7% 19.9% 17.3% 14.5% 12.4% 10.3% 8.5% 7.0% 6.2% 4.7% 1.0% 0.95%
EPS 3Y -4.5% 22.1% — — — — — — — — — 78.9% -35.3% — — — — — — — —
EPS 5Y 1.1% 42.3% 69.9% — 86.9% 1.6% 37.5% 30.2% 27.1% 27.6% — — — — — — — — — — —
Net Income 3Y -3.3% 24.4% — — — — — — — — — 74.9% -37.2% — — — — — — — —
Net Income 5Y 1.2% 43.4% 75.3% — 88.7% 1.7% 38.1% 30.5% 26.9% 27.2% — — — — — — — — — — —
EBITDA 3Y 35.0% 63.9% 3.6% — — — — 5.2% 1.2% 90.5% 72.1% 27.0% -8.3% -28.4% -52.3% -66.5% -61.9% -72.9% — — —
EBITDA 5Y — — — — 68.9% 71.8% 69.5% 56.0% 52.7% 54.6% 1.4% — — — — 52.5% -4.8% -23.8% — — —
Gross Profit 3Y 2.9% 9.1% 21.4% 32.8% 41.8% 46.7% 45.4% 43.1% 39.4% 36.0% 31.2% 20.0% 10.9% 2.4% -9.9% -18.9% -25.2% -29.0% -30.2% -30.5% -30.50%
Gross Profit 5Y 3.5% 5.6% 11.1% 16.4% 20.6% 22.8% 22.4% 20.9% 19.2% 18.1% 16.5% 13.7% 10.7% 8.5% 6.1% 4.8% 3.7% 2.8% 1.4% -2.4% -2.41%
Op. Income 3Y 58.3% 1.4% — — — — — — — — — 78.7% -25.5% — — — — — — — —
Op. Income 5Y 1.3% 85.6% 86.4% 1.2% 57.9% 61.9% 87.6% 77.8% 76.6% 98.3% — — — — — — — — — — —
FCF 3Y — — — — — 90.0% 2.6% 2.0% 2.1% 1.5% 1.2% — — — — — — -1.2% -31.6% -41.7% -41.67%
FCF 5Y — — — — — 17.6% 25.4% 30.7% 54.5% 46.2% 70.2% 65.3% 45.6% 70.3% 1.1% 73.3% 27.1% 24.3% 12.2% — —
OCF 3Y — — — — — 77.2% 1.9% 1.8% 1.8% 1.3% 1.1% — — — — — — -1.3% -28.9% -39.1% -39.14%
OCF 5Y — — — — — 16.2% 24.1% 29.6% 52.3% 44.2% 63.9% 58.9% 43.4% 60.5% 85.0% 64.6% 24.1% 22.2% 12.1% — —
Assets 3Y 2.4% 4.4% 19.7% 27.6% 33.2% 30.8% 35.3% 33.5% 29.9% 25.5% 23.9% 13.6% 6.9% 4.7% -7.0% -14.3% -16.1% -15.2% -22.0% -21.2% -21.16%
Assets 5Y 7.5% 7.4% 13.5% 20.0% 19.7% 14.1% 15.2% 14.9% 10.9% 9.1% 9.7% 8.0% 8.7% 8.7% 9.0% 8.3% 9.5% 8.5% 4.7% 0.4% 0.39%
Equity 3Y -6.7% -2.9% 11.0% 18.3% 35.8% 37.4% 41.1% 41.1% 46.8% 46.8% 45.3% 39.3% 31.8% 25.1% 12.1% 5.5% 0.1% -1.2% -11.0% -11.5% -11.54%
Book Value 3Y -7.9% -4.6% 8.9% 15.8% 33.5% 35.4% 39.8% 40.2% 47.6% 48.2% 48.1% 42.5% 35.9% 30.6% 18.0% 11.4% 5.3% 3.6% -6.9% -7.0% -7.01%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.54 0.45 0.41 0.46 0.49 0.53 0.63 0.71 0.69 0.65 0.64 0.56 0.39 0.26 0.16 0.06 0.01 0.00 0.00 0.02 0.018
Earnings Stability 0.00 0.01 0.12 0.28 0.34 0.43 0.48 0.47 0.49 0.47 0.55 0.41 0.27 0.20 0.09 0.03 0.00 0.03 0.24 0.39 0.389
Margin Stability 0.94 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.94 0.94 0.94 0.94 0.93 0.94 0.94 0.94 0.93 0.93 0.930
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.96 0.83 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.500
Earnings Smoothness — — — 0.00 0.00 0.00 0.65 0.89 0.46 0.24 0.11 0.00 0.00 — — — — — — — —
ROE Trend 0.47 0.57 0.66 0.65 0.51 0.46 0.23 0.08 -0.09 -0.19 -0.27 -0.32 -0.38 -0.38 -0.32 -0.26 -0.16 -0.15 -0.35 -0.34 -0.343
Gross Margin Trend -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.012
FCF Margin Trend -0.04 -0.03 -0.07 -0.04 -0.03 0.01 0.06 0.11 0.15 0.10 0.12 0.09 0.06 0.01 0.00 -0.00 -0.08 -0.04 -0.06 -0.06 -0.060
Sustainable Growth Rate 20.1% 32.3% 58.4% 66.0% 71.7% 71.1% 49.9% 38.6% 28.2% 22.9% 15.6% 10.0% 1.9% — — — — — — — —
Internal Growth Rate 8.8% 15.5% 32.0% 34.6% 43.1% 47.9% 28.9% 20.4% 17.0% 14.8% 9.8% 6.2% 1.3% — — — — — — — —
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.47 -0.17 -0.65 -0.51 -0.40 0.25 0.71 1.35 2.50 2.35 3.42 4.53 20.11 -61.16 -8.25 -6.75 -4.98 -3.46 -0.51 -0.48 -0.480
FCF/OCF 1.32 1.57 1.08 1.09 1.09 0.84 0.93 0.95 0.96 0.95 0.94 0.94 0.93 0.92 0.93 0.93 0.82 0.84 0.83 0.84 0.837
FCF/Net Income snapshot only -0.402
CapEx/Revenue 0.5% 0.5% 0.4% 0.4% 0.3% 0.3% 0.3% 0.4% 0.5% 0.6% 0.7% 0.7% 0.7% 0.6% 0.6% 0.7% 0.6% 0.8% 0.8% 0.8% 0.77%
CapEx/Depreciation snapshot only 0.493
Accruals Ratio 0.12 0.16 0.40 0.39 0.42 0.24 0.06 -0.06 -0.22 -0.17 -0.22 -0.21 -0.24 -0.17 -0.21 -0.22 -0.09 -0.12 -0.28 -0.28 -0.284
Sloan Accruals snapshot only -0.047
Cash Flow Adequacy snapshot only 6.121
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — — —
FCF Payout Ratio — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 6.5% 3.8% 1.7% 0.1% 0.1% 10.8% 18.8% 43.2% 57.7% 60.7% 79.4% 70.3% 5.0% — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.4% 0.3% 0.2% 0.0% 0.0% 2.3% 3.6% 8.2% 7.2% 7.1% 7.3% 5.0% 9.0% 8.9% 6.4% 6.5% 3.8% 1.0% 2.6% 4.2% 4.19%
Net Buyback Yield 0.4% 0.3% 0.2% 0.0% 0.0% 2.3% 3.6% 8.2% 7.2% 7.1% 7.3% 5.0% 9.0% 8.9% 6.4% 6.5% 3.8% 1.0% 2.6% 4.2% 4.19%
Total Shareholder Return 0.4% 0.3% 0.2% 0.0% 0.0% 2.3% 3.6% 8.2% 7.2% 7.1% 7.3% 5.0% 9.0% 8.9% 6.4% 6.5% 3.8% 1.0% 2.6% 4.2% 4.19%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.88 0.91 0.99 0.87 0.83 0.80 0.74 0.74 0.75 0.75 0.71 0.69 0.51 -3.64 0.89 0.85 1.17 0.97 1.14 1.14 1.142
Interest Burden (EBT/EBIT) 0.74 0.86 0.92 0.93 0.95 0.93 0.91 0.90 0.86 0.89 0.88 0.84 0.56 0.04 25.86 2.31 5.70 1.57 1.03 1.03 1.027
EBIT Margin 0.05 0.06 0.09 0.10 0.11 0.11 0.10 0.09 0.08 0.07 0.06 0.04 0.02 0.01 -0.00 -0.01 -0.00 -0.01 -0.08 -0.08 -0.084
Asset Turnover 2.53 2.85 3.08 3.14 3.57 4.02 3.34 2.87 2.84 2.81 2.48 2.26 2.29 2.22 2.12 2.05 2.06 1.99 2.03 1.95 1.951
Equity Multiplier 2.49 2.40 2.41 2.57 2.38 2.19 2.23 2.27 1.94 1.78 1.75 1.71 1.51 1.46 1.42 1.38 1.36 1.36 1.40 1.41 1.405
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.92 $1.57 $3.50 $4.60 $5.72 $6.06 $5.10 $4.26 $3.50 $2.91 $2.09 $1.33 $0.25 $-0.05 $-0.45 $-0.55 $-0.26 $-0.48 $-2.93 $-3.13 $-3.13
Book Value/Share $5.15 $5.77 $7.88 $9.38 $10.88 $11.27 $12.38 $12.36 $13.24 $13.36 $13.65 $13.53 $12.93 $12.85 $12.96 $12.95 $12.69 $12.55 $9.98 $9.94 $9.94
Tangible Book/Share $0.69 $1.43 $3.44 $5.01 $6.59 $7.00 $6.75 $6.76 $7.69 $7.72 $8.17 $7.91 $7.23 $7.05 $7.47 $7.53 $7.00 $6.91 $7.16 $6.61 $6.61
Revenue/Share $28.78 $33.30 $44.43 $56.25 $67.75 $75.19 $76.01 $72.23 $68.34 $63.55 $58.23 $51.34 $46.39 $43.80 $41.56 $38.98 $36.70 $34.67 $32.61 $31.84 $31.84
FCF/Share $-0.57 $-0.43 $-2.46 $-2.58 $-2.52 $1.26 $3.39 $5.46 $8.40 $6.48 $6.76 $5.64 $4.69 $2.99 $3.44 $3.45 $1.05 $1.40 $1.24 $1.26 $1.26
OCF/Share $-0.43 $-0.27 $-2.27 $-2.36 $-2.31 $1.50 $3.63 $5.74 $8.76 $6.85 $7.16 $6.00 $5.03 $3.27 $3.71 $3.71 $1.28 $1.67 $1.49 $1.50 $1.50
Cash/Share $0.49 $0.02 $0.03 $0.03 $0.01 $0.81 $0.10 $0.01 $0.02 $0.41 $0.49 $0.15 $2.05 $1.94 $2.52 $2.50 $2.50 $3.05 $3.36 $3.36 $3.36
EBITDA/Share $1.65 $2.26 $4.11 $5.95 $7.56 $8.47 $7.92 $6.76 $5.83 $4.84 $3.87 $2.80 $1.40 $0.94 $0.52 $0.26 $0.48 $0.19 $-1.99 $-2.17 $-2.17
Debt/Share $3.55 $3.16 $5.18 $6.27 $5.74 $3.73 $4.27 $3.99 $1.05 $0.17 $0.15 $0.13 $0.14 $0.13 $0.12 $0.10 $0.09 $0.07 $0.07 $0.06 $0.06
Net Debt/Share $3.06 $3.14 $5.15 $6.24 $5.73 $2.92 $4.17 $3.98 $1.04 $-0.24 $-0.34 $-0.02 $-1.91 $-1.80 $-2.40 $-2.40 $-2.41 $-2.98 $-3.29 $-3.29 $-3.29
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.811
Altman Z-Prime snapshot only 4.874
Piotroski F-Score 4 4 4 6 6 8 6 8 7 6 6 6 6 5 4 4 5 6 6 5 5
Beneish M-Score -1.40 -1.02 0.80 0.26 0.30 -0.79 -1.88 -2.69 -3.77 -3.56 -4.14 -3.98 -4.16 -3.67 -3.89 -3.97 -3.05 -3.22 -4.52 -4.36 -4.361
Ohlson O-Score snapshot only -7.679
ROIC (Greenblatt) snapshot only -35.51%
Net-Net WC snapshot only $5.09
EVA snapshot only $-37424960.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 70.19 75.56 78.24 76.59 80.29 91.05 90.51 90.20 89.99 90.39 90.43 91.69 89.96 82.30 63.88 63.38 63.52 64.57 62.88 61.28 61.281
Credit Grade snapshot only 8
Credit Trend snapshot only -2.099
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 34
Sector Credit Rank snapshot only 56

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms